Using extracellular biomarkers for monitoring efficacy of therapeutics in cancer patients: an update S. H. BeachyE. A. Repasky Review 10 January 2008 Pages: 759 - 775
Tumor-derived death receptor 6 modulates dendritic cell development David C. DeRosaPaul J. RyanRobert J. Benschop Original Article 26 October 2007 Pages: 777 - 787
Langerhans cells and dendritic cells are cytotoxic towards HPV16 E6 and E7 expressing target cells I. Caroline Le PooleWafic M. ElMasriW. Martin Kast Original Article 15 November 2007 Pages: 789 - 797
Vaccination with metastasis-related tumor associated antigen TPD52 and CpG/ODN induces protective tumor immunity Laura A. PaytonJennifer D. LewisRobert K. Bright Original Article 26 October 2007 Pages: 799 - 811
Regulatory T cells in colorectal cancer patients suppress anti-tumor immune activity in a COX-2 dependent manner Sheraz YaqubKaren HenjumKjetil Taskén Original Article 26 October 2007 Pages: 813 - 821
Mutation in the immunodominant epitope of the HPV16 E7 oncoprotein as a mechanism of tumor escape Michal SmahelPavla TejklovaJana Mackova Original Article 26 October 2007 Pages: 823 - 831
CD4+ T-cell recognition of human 5T4 oncofoetal antigen: implications for initial depletion of CD25+ T cells Eyad ElkordDeborah J. BurtPeter L. Stern Original Article 15 November 2007 Pages: 833 - 847
Dissection and molecular analysis of alloreactive CD8+ T cell responses in allogeneic haematopoietic stem cell transplantation Catherine WölfelVolker LennerzThomas Wölfel Original Article 15 November 2007 Pages: 849 - 857
Allogeneic tumor lysate can serve as both antigen source and protein supplementation for dendritic cell culture Peter DubskyHubert HaydenJosef Friedl Original Article 21 November 2007 Pages: 859 - 870
Human tankyrases are aberrantly expressed in colon tumors and contain multiple epitopes that induce humoral and cellular immune responses in cancer patients Yuriy V. ShebzukhovInna N. LavrikSergei A. Nedospasov Original Article 20 November 2007 Pages: 871 - 881
Rapid accumulation of adoptively transferred CD8+ T cells at the tumor site is associated with long-term control of SV40 T antigen-induced tumors Jodi L. YortySatvir S. TevethiaTodd D. Schell Original Article 15 November 2007 Pages: 883 - 895
Autologous versus allogeneic peptide-pulsed dendritic cells for anti-tumour vaccination: expression of allogeneic MHC supports activation of antigen specific T cells, but impairs early naïve cytotoxic priming and anti-tumour therapy Alison MerrickRosa Maria DiazAlan Melcher Original Article 04 December 2007 Pages: 897 - 906
Natural immunosurveillance against spontaneous, autochthonous breast cancers revealed and enhanced by blockade of IL-13-mediated negative regulation Jong Myun ParkMasaki TerabeJay A. Berzofsky Short Communication 15 November 2007 Pages: 907 - 912
Dendritic cell vaccination and other strategies to tip the balance of the immune system Niels SchaftKatrin BirkholzJan Dörrie Meeting Report 31 January 2008 Pages: 913 - 928
Dendritic cell vaccination and other strategies to tip the balance of the immune system Niels SchaftKatrin BirkholzJan Dörrie Erratum 27 February 2008 Pages: 929 - 930